Literature DB >> 9206946

[Transformation of glandular cystitis into bladder transitional carcinoma with adenocarcinoma areas].

D García Rojo1, A Prera Vilaseca, A Sáez Artacho, C Abad Gairín, J Prats López, M Rosa Bella Cueto.   

Abstract

OBJECTIVE: The association of cystitis glandularis with primary bladder tumors is well known. A case of cystitis glandularis progressing to transitional cell carcinoma is described and the literature briefly reviewed. METHODS/
RESULTS: We report on a case of diffuse cystitis glandularis in whom progression to transitional cell carcinoma with areas of adenocarcinoma had been discovered. Treatment was by radical cystectomy with urinary diversion.
CONCLUSION: Extensive and diffuse cystitis glandularis can be a potentially malignant lesion. Patients with diffuse cystitis glandularis should have a regular cystoscopic follow-up for early detection of progression to a bladder tumor.

Entities:  

Mesh:

Year:  1997        PMID: 9206946

Source DB:  PubMed          Journal:  Arch Esp Urol        ISSN: 0004-0614            Impact factor:   0.436


  3 in total

Review 1.  Large Cystitis glandularis: a very rare cause of severe obstructive urinary symptoms in an adult.

Authors:  Cevdet Kaya; Ihsan N Akpinar; Fugen Aker; Levent N Turkeri
Journal:  Int Urol Nephrol       Date:  2006-12-14       Impact factor: 2.370

2.  Intravesicular administration of sodium hyaluronate ameliorates the inflammation and cell proliferation of cystitis cystica et glandularis involving interleukin-6/JAK2/Stat3 signaling pathway.

Authors:  Yongliang Ni; Shaohua Zhao; Xiaoxuan Yin; Haixin Wang; Qianqian Guang; Guangxia Hu; Yi Yang; Shoubin Jiao; Benkang Shi
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

3.  The Efficacy and Safety of Transurethral 2 μm Laser Bladder Lesion Mucosal En Bloc Resection in the Treatment of Cystitis Glandularis.

Authors:  Changyuan Zhao; Kexin Wang; Chao Men; Yue Xin; Haibo Xia
Journal:  Front Med (Lausanne)       Date:  2022-03-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.